M&T Bank’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-71,382
Closed -$2.83M 1685
2024
Q4
$2.83M Buy
71,382
+10,121
+17% +$383K 0.01% 562
2024
Q3
$2.09M Buy
61,261
+10,223
+20% +$288K 0.01% 670
2024
Q2
$1.11M Buy
51,038
+5,399
+12% +$114K ﹤0.01% 836
2024
Q1
$1.01M Buy
45,639
+11,051
+32% +$270K ﹤0.01% 877
2023
Q4
$951K Buy
34,588
+5,496
+19% +$133K ﹤0.01% 886
2023
Q3
$649K Sell
29,092
-1,642
-5% -$42.2K ﹤0.01% 978
2023
Q2
$783K Buy
30,734
+6,574
+27% +$159K ﹤0.01% 956
2023
Q1
$538K Sell
24,160
-8,176
-25% -$198K ﹤0.01% 1081
2022
Q4
$768K Buy
32,336
+406
+1% +$9.44K ﹤0.01% 949
2022
Q3
$531K Sell
31,930
-4,966
-13% -$112K ﹤0.01% 1064
2022
Q2
$734K Buy
36,896
+22,472
+156% +$454K ﹤0.01% 869
2022
Q1
$398K Buy
14,424
+2,895
+25% +$82.8K ﹤0.01% 1085
2021
Q4
$475K Buy
11,529
+629
+6% +$27.8K ﹤0.01% 1051
2021
Q3
$506K Sell
10,900
-206
-2% -$8.99K ﹤0.01% 1002
2021
Q2
$444K Buy
11,106
+1,224
+12% +$52.3K ﹤0.01% 1087
2021
Q1
$531K Sell
9,882
-4,268
-30% -$246K ﹤0.01% 966
2020
Q4
$692K Sell
14,150
-1,263
-8% -$58.5K ﹤0.01% 904
2020
Q3
$501K Buy
15,413
+1,863
+14% +$59.2K ﹤0.01% 994
2020
Q2
$351K Buy
13,550
+867
+7% +$21.6K ﹤0.01% 1115
2020
Q1
$308K Buy
+12,683
New +$319K ﹤0.01% 1117

Other funds holding VCYT

M&T Bank's VCYT Position: Q1 2025 in Review

M&T Bank sold out of Veracyte (VCYT) in Q1 2025, closing a stake of 71,382 shares — an estimated $2.83M sold.

M&T Bank first reported a position in VCYT in Q1 2020 and held it in 20 quarters. The position peaked at $2.83M in Q4 2024. 287 funds tracked by Wall St. Rank hold VCYT as of Q1 2025.

  • M&T Bank reported no remaining Veracyte position as of Q1 2025 after selling out during the quarter.
  • M&T Bank sold 71,382 Veracyte shares in Q1 2025, an estimated $2.83M.
  • M&T Bank first reported a position in Veracyte in Q1 2020 and held it in 20 quarters.
  • M&T Bank's Veracyte position peaked at $2.83M in Q4 2024.
  • 287 funds tracked by Wall St. Rank held Veracyte as of Q1 2025.

Based on M&T Bank's 13F filing for Q1 2025, filed 30 Apr 2025.